Epstein-Barr Virus Antibody to Viral Capsid Antigen, IgM
Ordering Recommendation
Aids in the diagnosis of primary Epstein-Barr virus infectious mononucleosis, in conjunction with other serologic tests. Not a stand-alone test.
New York DOH Approval Status
Specimen Required
Serum separator tube (SST).
Allow specimen to clot completely at room temperature. Separate from cells ASAP or within 2 hours of collection. Transfer 2 mL serum to an ARUP standard transport tube. (Min: 0.5 mL) Parallel testing is preferred and convalescent specimens must be received within 30 days from receipt of the acute specimens.
Refrigerated.
Contaminated, heat-inactivated, icteric, or grossly hemolyzed specimens.
Label specimens plainly as ''acute'' or ''convalescent.''
After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles)
Methodology
Semi-Quantitative Chemiluminescent Immunoassay
Performed
Sun-Sat
Reported
1-2 days
Reference Interval
Test Number |
Test Name |
Reference Interval |
---|---|---|
0050240 | EBV Antibody to Viral Capsid Antigen IgM | <=35.9 U/mL |
Interpretive Data
35.9 U/mL or less: Not Detected
36.0-43.9 U/mL: Indeterminate. Repeat testing in 10-14 days may be helpful.
44.0 U/mL or greater: Detected
FDA
Note
EBV IgM values obtained with different manufacturers' assay methods may not be used interchangeably. The magnitude of the reported EBV IgM level cannot be correlated to an endpoint titer.
Hotline History
Hotline History
CPT Codes
86665
Components
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
0050240 | EBV Antibody to Viral Capsid Antigen IgM | 7886-5 |
Aliases
- EBV Antibodies
- EBV VCA-IgM Ab
- EBV Ab and VCA IgM Ab
- EBV Antibody to Viral Capsid Antigen
- EBV VCA